Lecanemab: Breakthrough Alzheimer’s Disease Medication Déjà vu
In this episode of Minding Memory, we dive into the newest FDA-approved drug to treat Alzheimer’s – Lecanemab – with Ohio State University stroke neurologist Jim Burke.
Get CAPRA news in your inbox
Subscribe now to stay informed with the latest news and insights from CAPRA!